Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Oncogene

• Publication date

  2006-02-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1209137PMID 16186793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The theoretical basis of transcriptional therapy of cancer: can it be put into practice?

  2005cited by this paper
• Role of the Ras-association domain family 1 tumor suppressor gene in human cancers.

  2005cited by this paper
• Somatostatin Receptor Subtype 2 Is Expressed by Supratentorial Primitive Neuroectodermal Tumors of Childhood and Can Be Targeted for Somatostatin Receptor Imaging

  2004cited by this paper
• Epigenetics in human disease and prospects for epigenetic therapy

  2004cited by this paper
• Chromosomal imbalances detected by comparative genomic hybridisation in atypical teratoid/rhabdoid tumours

  2004cited by this paper
• Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.

  2003cited by this paper
• The WHO Classification of Tumors of the Nervous System

  2002cited by this paper
• Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System: Report on Workshop

  2002cited by this paper
• Expression and methylation of CASP8 in neuroblastoma: Identification of a promoter region

  2002cited by this paper
• Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential.

  2002cited by this paper
• Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines.

  2002cited by this paper
• No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors

  2002influential reference
• Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

  2002cited by this paper
• Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma.

  2002cited by this paper
• Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.

  2001cited by this paper
• Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas–Implications for tumor biology and potential clinical utility

  2001cited by this paper
• Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.

  2000cited by this paper
• Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

  2000cited by this paper
• Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon

  2000cited by this paper
• Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

  2000cited by this paper
• TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.

  2000cited by this paper
• Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.

  1999cited by this paper
• Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors

  1999cited by this paper
• Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.

  1998cited by this paper
• Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor

  1992cited by this paper

• Screening Key Pathogenic Genes and Small Molecule Compounds for PNET

  2022cites this paper
• Differential and Common Signatures of miRNA Expression and Methylation in Childhood Central Nervous System Malignancies: An Experimental and Computational Approach

  2021influential citation
• Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors

  2021cites this paper
• Malignant Rhabdoid Tumors and Tumors with Rhabdoid Features

  2016cites this paper
• Quantitative analysis of DNA methylation in the promoter region of the methylguanine‐O6‐DNA‐methyltransferase gene by COBRA and subsequent native capillary gel electrophoresis

  2015cites this paper
• Analysis of the antiproliferative effects of 3-deazaneoplanocin A in combination with standard anticancer agents in rhabdoid tumor cell lines.

  2015cites this paper
• The potential for epigenetic analysis of paediatric CNS tumours to improve diagnosis, treatment and prognosis.

  2015cites this paper
• The role of RASSF 1 A methylation in cancer

  2014cites this paper
• The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells

  2013cites this paper
• Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system

  2013cites this paper
• The molecular basis for central nervous system primitive neuroectodermal tumour development

  2012cites this paper
• Atypical Teratoid Rhabdoid Tumors (ATRTs): The British Columbia's Children's Hospital's Experience, 1986–2006

  2012influential citation
• Medulloblastoma: Therapy with Bortezomib/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

  2012cites this paper
• Deregulated Chromatin Remodeling in the Pathobiology of Brain Tumors

  2012cites this paper
• Supratentorial Primitive Neuroectodermal Tumor: Biology

  2012cites this paper
• RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell lines.

  2011cites this paper
• Epigenetics in Pediatric Cancers

  2011cites this paper
• Epigenetic mechanisms regulating neural development and pediatric brain tumor formation.

  2011cites this paper
• The CpG Island Methylation Regulated Expression of Endothelial Proangiogenic Genes in Response to β-Carotene and Arachidonic Acid

  2011influential citation
• The Role of Cell Adhesion Genes in the Pathogenesis of Medulloblastoma

  2011cites this paper
• 9 – Embryonal (Primitive) Neoplasms of the Central Nervous System

  2010cites this paper
• Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines

  2010cites this paper
• The Genetics of Pediatric Brain Tumors

  2010cites this paper
• Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.

  2010cites this paper
• Accurate quantification of DNA methylation of DRD4 applying capillary gel electrophoresis with LIF detection

  2009cites this paper
• MGMT as a potential stratification marker in relapsed high‐grade glioma of children: The HIT‐GBM experience

  2009cites this paper
• Non‐pineal supratentorial primitive neuro‐ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio‐spinal irradiation?

  2009influential citation
• The importance of radiotherapy in paediatric atypical teratoid rhabdoid tumour of the brain

  2009cites this paper
• Tumors of the Brain and Spinal Cord

  2009cites this paper
• Frequent RASSF1A Gene Promoter Hypermethylation in Breast Cancer

  2008cites this paper
• Frequent RASSF 1 A Gene Promoter Hypermethylation in Breast Cancer

  2008cites this paper
• Medulloblastoma, Primitive Neuroectodermal Tumors, and Pineal Tumors

  2008cites this paper
• Tumours: introduction and neuroepithelial tumours

  2008cites this paper
• The Epigenetics of Cancer in Children

  2008cites this paper
• Aberrant MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation in choroid plexus tumors

  2008cites this paper
• Frequent but borderline methylation of p16INK4a and TIMP3 in medulloblastoma and sPNET revealed by quantitative analyses

  2007cites this paper
• RASSF1A promoter is highly methylated in primitive neuroectodermal tumors of the central nervous system

  2007cites this paper
• The Role of RASSF1A Methylation in Cancer

  2007cites this paper
• Inhibitors of histone deacetylases as potential therapeutic tools for high‐risk embryonal tumors of the nervous system of childhood

  2007cites this paper
• Novel role for insulin as an autocrine growth factor for malignant brain tumour cells.

  2007cites this paper